PLAMUMAB 40MG INJECTION

Plamumab 40mg Injection contains Adalimumab, a potent ingredient under TNF (tumor necrosis factor) inhibitors. It’s primarily used to counteract the effects of certain autoimmune diseases that cause the body to attack its joints and tissues, resulting in pain, swelling, and impaired function. This medication can be used alone or in combination with other drugs to manage rheumatoid arthritis and polyarticular juvenile idiopathic arthritis effectively, two common autoimmune disorders that affect joint health. The medication is also prescribed to treat a range of inflammatory conditions, including  arthritis, ankylosing spondylitis (a condition characterized by joint pain and damage in the spine and other areas), axial without radiographic evidence of ankylosing spondylitis, psoriatic arthritis (a condition that causes joint pain and swelling and skin scaling), plaque psoriasis, hidradenitis suppurative (a skin disease that causes pimple-like bumps in the armpits, groin, and anal area), Crohn’s disease, ulcerative colitis (a condition that causes swelling and sores in the colon and rectum lining), and non-infectious uveitis (swelling and inflammation in various areas of the eye). Avoid utilizing Plamumab 40mg Injection if you have an allergy to Adalimumab or any other component of this medication. This medication should not be taken if you have tuberculosis or other active infections. If you have moderate or severe heart failure, avoid using this medication. Inform your physician if you have an active infection before beginning treatment. Before starting treatment, let your doctor know if you have any lung, heart, liver, or kidney issues. If you’re pregnant, think you might be pregnant, or plan to become pregnant, ask your doctor for advice on taking this medication.